Table 1.
The relationship between Fdft1 expression and clinicopathological features in 81 CRC patients from FUSCC.
Fdft1 | |||||
---|---|---|---|---|---|
Variable | Number | Low expression | High expression | X2 test | |
P-value | |||||
Age (years) | <60 | 51 | 27 | 24 | 0.798 |
≥60 | 30 | 15 | 15 | ||
Gender | Female | 60 | 33 | 27 | 0.338 |
Male | 21 | 9 | 12 | ||
Tumor location | Colon | 30 | 12 | 18 | 0.102 |
Rectum | 51 | 30 | 21 | ||
Size | <5 cm | 42 | 15 | 27 | 0.003* |
≥5 | 39 | 27 | 12 | ||
Histological type | Adenocarcinoma | 66 | 30 | 36 | 0.016* |
Mucinous adenocarcinoma | 15 | 12 | 3 | ||
Lymph node metastasis | No | 42 | 12 | 30 | 0.000*** |
Yes | 39 | 30 | 9 | ||
Tumor differentiation | Well, moderate | 60 | 27 | 33 | 0.037* |
Poor and others | 21 | 15 | 6 | ||
Invasion | T1–2 | 21 | 6 | 15 | 0.013* |
T3–4 | 60 | 36 | 24 | ||
Distant metastasis | No | 75 | 36 | 39 | 0.043* |
Yes | 6 | 6 | 0 | ||
Clinical stage | I–II | 30 | 9 | 21 | 0.003** |
III–IV | 51 | 33 | 18 | ||
CEA | < 5 ng/ml | 54 | 24 | 30 | 0.059 |
≥5 ng/ml | 27 | 18 | 9 |
Pearson’s X2 tests were used. The results were considered statistically significant at P < 0.05. *P < 0.05, **P < 0.01, ***P < 0.001.